SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-292254
Filing Date
2020-11-13
Accepted
2020-11-13 07:16:00
Documents
2
Period of Report
2020-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d86430d8k.htm 8-K 17060
2 EX-99.1 d86430dex991.htm EX-99.1 45369
  Complete submission text file 0001193125-20-292254.txt   63561
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39425 | Film No.: 201309149
SIC: 2836 Biological Products, (No Diagnostic Substances)